AU9740998A - Piperidine derivatives against malaria - Google Patents

Piperidine derivatives against malaria

Info

Publication number
AU9740998A
AU9740998A AU97409/98A AU9740998A AU9740998A AU 9740998 A AU9740998 A AU 9740998A AU 97409/98 A AU97409/98 A AU 97409/98A AU 9740998 A AU9740998 A AU 9740998A AU 9740998 A AU9740998 A AU 9740998A
Authority
AU
Australia
Prior art keywords
piperidine derivatives
against malaria
derivatives against
malaria
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU97409/98A
Inventor
Daniel Bur
Walter Fischli
Hugues Matile
Robert George Ridley
Wolfgang Wostl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU9740998A publication Critical patent/AU9740998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU97409/98A 1997-09-08 1998-09-02 Piperidine derivatives against malaria Abandoned AU9740998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97115510 1997-09-08
EP97115510 1997-09-08
PCT/EP1998/005570 WO1999012532A2 (en) 1997-09-08 1998-09-02 Piperidine derivatives against malaria

Publications (1)

Publication Number Publication Date
AU9740998A true AU9740998A (en) 1999-03-29

Family

ID=8227323

Family Applications (1)

Application Number Title Priority Date Filing Date
AU97409/98A Abandoned AU9740998A (en) 1997-09-08 1998-09-02 Piperidine derivatives against malaria

Country Status (2)

Country Link
AU (1) AU9740998A (en)
WO (1) WO1999012532A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
AU2001291830A1 (en) * 2000-09-25 2002-04-02 Actelion Pharmaceuticals Ltd. Substituted amino-aza-cycloalkanes useful against malaria
WO2003043987A2 (en) * 2001-11-19 2003-05-30 Elan Pharmaceuticals, Inc. (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004105762A1 (en) * 2003-05-30 2004-12-09 Actelion Pharmaceuticals Ltd Medical use of diazabicyclononene derivatives as inhibitors of parasite aspartic proteases
EP1707202A1 (en) * 2005-03-31 2006-10-04 Speedel Experimenta AG Organic compounds
EP1707206A1 (en) * 2005-03-31 2006-10-04 Speedel Experimenta AG Piperazine derivates for the inhibition of beta-secretase, cathepsin D, plasmepsin ll and HIV protease and for the treatment of malaria, Alzeheimer and AIDS
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
EP1987834A3 (en) * 2007-02-13 2008-11-19 Speedel Experimenta AG Substituted piperidines as therapeutic compounds
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
JP5133416B2 (en) 2007-09-14 2013-01-30 オルソー−マクニール−ジャンセン ファーマシューティカルズ， インコーポレイテッド． 1 ', 3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H, 1'H- [1,4'] bipyridinyl-2'-one
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2430031B1 (en) 2009-05-12 2013-04-17 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
EP2301627A1 (en) * 2009-09-22 2011-03-30 University of Graz Novel antimalarial 3-azabicyclo[3.2.2]nonane derivatives
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
WO2012062750A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
PL3431106T3 (en) 2014-01-21 2021-06-28 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914235A (en) * 1968-07-02 1975-10-21 Hoffmann La Roche Processes and intermediates for quinine, quinidine, isomers and derivatives thereof
CH605916A5 (en) * 1973-12-07 1978-10-13 Hoffmann La Roche
ES2201192T3 (en) * 1995-09-07 2004-03-16 F. Hoffmann-La Roche Ag NEW 4- (OXIALCOXIFENIL) -3-OXI-PIPERIDINS FOR THE TREATMENT OF CARDIAC AND RENAL INSUFFICIENCY.

Also Published As

Publication number Publication date
WO1999012532A2 (en) 1999-03-18
WO1999012532A3 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
AU9740998A (en) Piperidine derivatives against malaria
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU9281298A (en) Benzodioxole derivatives
AU2942000A (en) Novel piperidine derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
ZA9811345B (en) Piperidine derivatives
AUPO735997A0 (en) Piperazine derivatives
AU7080698A (en) Novel dihydropyridine derivative
AU7813598A (en) Betulinol derivatives
AU9160098A (en) Packer
AU8925998A (en) Huperzine a derivatives
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AUPO863197A0 (en) Novel derivatives
AU5937998A (en) Phenoxymethyl piperidine derivatives
AU7557000A (en) Piperidine derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU6115798A (en) Saponarin derivatives
AU5568200A (en) Dihydropyridine derivative
AU8130298A (en) Piperazine derivatives
AU8338098A (en) Peroxyacids
AU5336498A (en) Barrier
AU2158197A (en) Piperidine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase